IMRAN MIR A 4
4 · Rani Therapeutics Holdings, Inc. · Filed Feb 7, 2022
Insider Transaction Report
Form 4
IMRAN MIR A
Director
Transactions
- Other
Class A Common Stock
2022-02-03+67,707→ 67,707 total(indirect: See footnote) - Other
Class A Common Stock
2022-02-03−827,467→ 0 total(indirect: See footnote)
Footnotes (4)
- [F1]Biologix Partners, LP and VH Rani, LP. distributed these shares to its limited partners on a pro rata basis, for no consideration.
- [F2]Represents previously held 378,564 shares of Class A Common Stock of the Issuer ("Class A Shares") held by Biologix Partners, LP and 448,903 Class A Shares held by VH Rani, LP.
- [F3]InCube Ventures II, L.P., is the limited partner of Biologix Partners, LP and VH Rani, LP. InCube Ventures II, L.P. therefore received 12,289 Class A Shares distributed by Biologix Partners, LP and 41,495 Class A Shares distributed by VH Rani, LP. and now owns those shares directly. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F4]InCube Labs, L.L.C., is the limited partner of Biologix Partners, LP and VH Rani, LP. InCube Labs, L.L.C. therefore received 3,181 Class A Shares distributed by Biologix Partners, LP and 10,742 Class A Shares distributed by VH Rani, LP. and now owns those shares directly. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.